SCHEMBL369750

SCHEMBL369750

Cc1cc(Cl)ccc1C(CC(=O)c1ccc(=O)n(C)c1)c1ccc(N)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.40
CYP2C9 P11712 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
CYP2C19 P33261 2/20 0.35
MGAM O43451 2/20 0.35
GAA P10253 2/20 0.35
SI P14410 2/20 0.35
MGAM2 Q2M2H8 2/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
KMT2A Q03164 2/20 0.34
CREBBP Q92793 1/20 0.34
PRKCZ Q05513 1/20 0.34
FFAR1 O14842 1/20 0.34
GABBR2 O75899 2/20 0.33
GABBR1 Q9UBS5 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
CYP3A4 P08684 1/20 0.33
ADORA3 P0DMS8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15832896 0.92 POLB (0.39) POLBCYP2C9L3MBTL1CYP2C19MGAM
SCHEMBL369581 0.92 POLB (0.40) POLBCYP2C9L3MBTL1CYP2C19MGAM
SCHEMBL371309 0.91 POLB (0.40) POLBCYP2C9L3MBTL1CYP2C19MGAM
SCHEMBL368816 0.90 KMT2A (0.46) POLBCYP2C9L3MBTL1CYP2C19MGAM
SCHEMBL370765 0.89 CYP2C9 (0.39) POLBCYP2C9L3MBTL1CYP2C19MGAM
SCHEMBL1390512 0.88 CHRNA7 (0.37) POLBCYP2D6
SCHEMBL1390419 0.88 LMNA (0.43) POLBCYP2C9L3MBTL1CYP2C19KEAP1
SCHEMBL370157 0.87 GPBAR1 (0.39) POLBCYP2C9CYP2C19MGAMGAA
SCHEMBL15832830 0.87 GPBAR1 (0.40) POLBKEAP1NFE2L2CREBBPPRKCZ
Formic Acid SCHEMBL27924258 0.87 BRD4 (0.39) POLBMGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 POLB 2940/4885CYP2C9 1676/4885L3MBTL1 2596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.